News MIT team develops 'years-long' drug delivery tech Researchers in the US have devised a new depot system that could provide months or even years of delivery from a single subcutaneous injection.
News AbbVie builds the case for ovarian cancer drug Elahere AbbVie hopes for another lift to its fast-growing ovarian cancer drug Elahere with new survival data.
News 'Transformational' pill for endometriosis gets NHS nod Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy, Gedeon Richter's Ryeqo, via the NHS.
Patients The state of women’s health in the UK: A parliamentary round... The UK faces one of the largest gender health gaps among G20 nations and women’s health challenges remain significantly, unacceptably underserved.
R&D Reimagining women's health in the 21st century Imagine a world where medical research routinely excluded men... That's the reality many women face when it comes to healthcare.
News AstraZeneca builds in China as Cosette buys Mayne The reporting week has ended with a flurry of M&A as Cosette Pharma and AstraZeneca agree takeover deals.
News 23andMe fined £2.31m over UK users' genetic data breach Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face